Diabetes, Heart Disease, Quality of Life
Conditions
Keywords
Promotion health
Brief summary
The purpose of this study is to evaluate whether the introduction of large-scale personalized and technology supported telemonitoring and health coaching interventions produces benefits in terms of health related quality of life, health status and empowerment of patients with a cardiovascular disease. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.
Interventions
PROCEDUREHealth Coaching and Life-long Monitoring
Participants receive tablet PCs with software that collects and transmit diagnostic measurements. Measurements are performed by the participants following indications of the health coaching team. Equipment used by all participants: • blood pressure meter, • pedometer • pulse watch• 2-channel electrocardiograph. Measured values are entered manually by the participants, unrealistic values are refused and values are provided with a time-stamp. Measurements is reviewed in a graphical display. Measured values are accessed by the health coaching team that develops an individualized measurement and medication scheme. Reminders are provided by the software and can be exported to personal calendars or mobile phones. Secure authentication of users is be provided
Sponsors
County Council of Norrbotten, Sweden
Luleå Tekniska Universitet
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of arterial hypertension ischemic heart disease, * atrial fibrillation or other arrhythmia, * congestive heart failure (study heart disease) * HbA1C \> 53mmol/mol (study diabetes) * Age \> 18 years * Capability of filling in questionnaires in the own language * Capability to use the devices provided * Being cognitively able to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| SF-36 | 12 months follow-up | Questionnaire, 36 questions ref Ware, 2000 version 2 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bloodpressure | 12 months follow-up | — |
| Blood lipids | 12 months follow-up | — |
| Bodyweight | 12 months follow-up | — |
| HbA1c (for patients with type-2D) Blood pressure for patient with heart disease | 12 months follow-up | HbA1c is a long-term sugar / serum glucose test, it is a blood test that gives a measure of blood sugar levels two to three months before sampling. |
| Alcohol consumption | 12 months follow-up | — |
| SOC-13 | 12 months follow-up | SOC-13 (sense of coherence, SOC) is a term that reflects the ability to cope with stress and is the essence of the salutogenic theory of health. SOC consists of three subordinate concepts, manageability, meaningfulness and comprehensibility. |
| EQ-5D | 12 monts follow-up | EQ5D (5d) is a standardized instrument to measure and describe health outcomes. It can be used to measure health at the individual level in clinical settings and to measure a population's health locally and nationally. |
| Smoking habits | 12 months follow-up | — |
Countries
Sweden
Outcome results
None listed